ReNetX Bio Launched to Advance Innovative Neuro-Regenerative Technology Developed at Yale University
Jul 24, 2017 11:30 am UTC| Business
Company Appoints Erika R. Smith as CEO; Previously Director at Yale Innovation Fund Initiates Series A Financing Round to Fund Clinical Trial in Chronic Spinal Cord Injury NEW HAVEN, Conn., July 24, 2017 -- ReNetX...
Jul 24, 2017 11:25 am UTC| Business
Dublin, July 24, 2017 -- The "Global Breast Implants Market - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023" report has been added to Research and Markets' offering. ...
Jul 24, 2017 11:19 am UTC| Business
Dublin, July 24, 2017 -- The "Specialty Chemicals - A Global Market Overview" report has been added to Research and Markets' offering. Worldwide market for specialty chemicals...
Key IoT Technologies Unlocking the IoT Potential Markets 2017-2025
Jul 24, 2017 11:10 am UTC| Business
Dublin, July 24, 2017 -- The "Key IoT technologies: Unlocking the IoT Potential" report has been added to Research and Markets' offering. This report identifies the emerging...
NXP Announces Executive Management Transition
Jul 24, 2017 11:04 am UTC| Business
EINDHOVEN, Netherlands, July 24, 2017 -- NXP Semiconductors N.V. (NASDAQ:NXPI) announced today that, effective August 6, 2017, Chief Financial Officer Daniel Durn is leaving the company to become the Chief Financial...
Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes
Jul 24, 2017 11:00 am UTC| Business
- Statistically significant result on expected Phase 3 primary endpoint with Phase 3 dose -- Positive results on multiple secondary clinical endpoints -- Potentially the first new treatment in more than 20 years for the...
Sarepta Therapeutics Announces Proposed $250 Million Public Offering of Common Stock
Jul 24, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., July 24, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the...